This content is from:Premium Hedge Funds Surface in Wave of Biopharma SPAC Deals RTW and Perceptive Advisors are among investors seen in recent SPAC deals in biopharma. ByStephen Taub October 19, 2020
This content is from:Premium One of the Best-Performing Hedge Funds in Recent Years Just Got Richer Why Avoro Capital Advisors cheered Gilead’s deal to acquire Immunomedics. ByStephen Taub September 16, 2020
This content is from:Premium Rokos, Impala, Carlson Disclose Major Buys The hedge funds were among firms that disclosed their first quarter long positions in U.S. equities ahead of the filing deadline. ByStephen Taub May 14, 2021
This content is from:Premium Carl Icahn’s Investment Portfolio Gets a Shot of Energy The octogenarian is hoping to snap a two-year losing streak. ByStephen Taub May 11, 2021
This content is from:365亚博 Why Investing by Country Is the Wrong Way to Approach Equity Portfolios 自从资产配置策略也易elded higher risk-adjusted results over the last 45 years, according to new research. ByJessica Hamlin May 11, 2021
This content is from:Premium Icahn’s Investment Funds Report Double-Digit Loss for Second Straight Year But a recent run up in energy stocks may boost the portfolio this quarter. ByStephen Taub March 05, 2021
